Pharmafile Logo

Glaucoma in perspective

- PMLiVE

Pharma ‘getting away with murder’, says Trump

Almost $25bn wiped off big pharma stocks as US President-elect turns attention to drug pricing

Challenging times

It’s not an easy time for pharma, but there are opportunities for those companies that are willing to be true game changers

- PMLiVE

AstraZeneca appoints head of oncology

Dr Jamie Freedman joins from AZ subsidiary MedImmune

- PMLiVE

Ipsen’s chief scientific officer steps down

Dr Claude Bertrand will be replaced ad interim by Alexandre Lebeaut

National Institute for Health and Care Excellence NICE logo

NICE recognises Smartinhaler as best practice for asthma care

Digital monitoring device proven to increase adherence and reduce hospital visits

- PMLiVE

Ashley Communications celebrates 20 years of medical communications

Looks forward with new business wins, including AbbVie and Merck & Co accounts

- PMLiVE

Wales unveils ‘sensible’ £80m medicines access fund

New scheme hopes to provide greater consistency and accelerate availability by eight weeks

- PMLiVE

Kite bags $90m upfront in two Asian deals for lead CAR-T drug

Partners with Daiichi Sankyo and Fosun Pharma to focus in on non-Hodgkin lymphoma

- PMLiVE

The modern doctor is a digital nomad

How social networks have become the primary individual communication platforms for healthcare professionals

- PMLiVE

Former AZ oncology head joins Innate Pharma

Dr Mondher Mahjoubi becomes chairman of the executive board at the French biotech

- PMLiVE

Voyager Therapeutics appoints chief financial officer

Jane Pritchett Henderson joins the gene therapy specialist

- PMLiVE

Synergy Vision marks its first decade with fundraising initiative

Pledges to undertake 10 challenges to raise money for two charitable causes

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links